boston scientific

This weekend's Barron's cover story reveals the third annual ranking of America's most sustainable companies. Other featured articles explain why oil stocks may have hit bottom and offer a look at how the coronavirus outbreak is affecting health care companies. Also, the prospects for...

Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...

Featured stories this weekend in Barron's ponder the prospects for networking underdog and a former newspaper publisher. The prospects for a Midwest asset manager and a bright spot in retail are also examined. Another article suggests that a "death spiral" is coming for electric utilities. "...

The cover story in this weekend's Barron's features three fund managers reveling in the market turmoil. This issue also includes the Barron's quarterly guide to mutual funds. The prospects for Tenet Healthcare, Boston Scientific, high-yield bonds, Tessera Technologies, 1-800-Flowers and more are...

Whether the past week's volatility, and the apparent and long overdue correction, has brought out bargain hunters remains to be seen. However, it is clear that insiders and beneficial owners have come out to take advantage of the turmoil. Conventional wisdom says that insiders and beneficial owners...

U.S. stocks declined for the second straight day after investors and traders digested disappointing earnings from retailers and economic reports were disappointing. The Dow suffered a triple-digit point loss and declined one percent after the retailer giant Wal-Mart failed to "wow" investors....

U.S. stocks finished higher as the Dow approached its all time high of 16,631.60. The index trading on Tuesday as high as 16,559.39. The S&P 500 index is also not that far away from its all time highs of 1,897.28. The Federal Open Market Committee began its two-day meeting in Washington....

The earnings crunch continues this week. Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter. Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings...

January, with its five percent correction, is behind us, and earnings continue to roll out this week, whether or not the groundhog saw his shadow. Highlights will include quarterly results from General Motors (NYSE: GM), Merck (NYSE: MRK), Philip Morris (NYSE: PM) and Walt Disney (NYSE: DIS),...

Record cold temperatures are gripping much of the nation but expect the U.S. markets to return to business as usual this week now that the holiday season is over. Investors will watch Washington as the monthly jobs report hits the market Friday as well as minutes from the Federal Reserve’s most...

Major indices continued its decline from yesterday as the Dow suffered a triple digit point loss for the second consecutive day. Positive retail sales data added to an otherwise already convincing case that the economy is strong enough for the Federal Reserve to begin tapering. The Fed's policy...

Thursday is Thanksgiving, and most Thanksgiving get-togethers include the classic question, “what are you thankful for?” If you’re an investor and you’ve held any of these stocks since the beginning of the year, while others talk about health and happiness, you might mention your portfolio....

Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who...